Comparison of the percentage of CD8+CTLA4+ T lymphocytes in selected types of PAH and in the control group revealed a significantly higher percentage of these lymphocytes in the group of patients with iPAH than in the control group (p < 0.001). This evidence concerns the gene CD8A and pulmonary arterial hypertension.